Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With Asthma
Clinical trial NCT00685022 · COMPLETED
Trial details
- NCT number
- NCT00685022
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
- Primary completion
- 2003-08-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.